Lauri Strauss Memorial Grand Round Lectures
Delivered Annually at Memorial Sloan Kettering Cancer Center, New York, NY
 

2015-2016
Ravinda Majeti, MD
Associate Prof. of Medicine(Hematology)
Stanford School of Medicine, Stanford, CA
AML Stem Cells: Biology, Clinical Significance, and Therapeutic Targeting

2014-2015
Ross Levine, MD
Memorial Sloan Kettering Cancer Center, New York, NY
The Genetics and Therapeutics of Acute Myeloid Leukemia(AML)

2013-2014
Scott Armstrong, MD
Memorial Sloan Kettering Cancer Center, New York, NY
Targeting Histone methylation for Leukemia

2012-2013
Donald Small, MD, PhD
Delivered at Memorial Sloan Kettering Cancer
Center, New York, NY
Sidney Kimmel Comprehensive Cancer Center

2010-2011
Martin Tallman, MD
Memorial Sloan Kettering Cancer Center,
New York, NY
Crossing the Great Divide in Acute Myeloid Leukemia

2008-2009
Kenneth C. Anderson, MD
Dana Farber Cancer Institute, Boston, MA
Oncogenomics To Target Myeloma in the Bone Marrow Microenviornment


2006-2007
Charles L. Sawyers, MD
Memorial Sloan Kettering Cancer Center,
New York, NY
Kinase Inhibitors: Lessons from Chronic Myeloid Leukemia

2004-2005
Hagop M. Kantarjian, MD
M.D. Anderson Cancer Center, Houston, TX
A Tale of Two Nucleosides: Clofarbine and Decitabine

2003-2004
George J. Weiner, MD
Holden Comprehensive Cancer Center,
Iowa City, IA
Immunotherapy of B-cell Malignancies with Monoclonal Antibodies and Immuno Stimulatory CpG ODN

2002-2003
Jonathan D. Licht, MD
Feinberg School of Medicine, Northwestern University Chicago, IL
Targeting Transcriptional Repression in Hematological Malignancy

2001-2002
Irwin D. Bernstein, MD
Fred Hutchinson Cancer Research Center
University of Washington School of Medicine
Children’s Hospital and Regional Medical Center
Seattle, WA
Notch Regulation of Hematopoietic Stem Cells

2000-2001
Alan D. D’Andrea, MD
Harvard Medical School, Boston, MA
Inherited Chromosome Instability and Cancer


1999-2000
Rick VanEtten, MD, PhD
Tufts-New England Medical Center,
Boston, MA
Transformation and Leukemogenesis by the Abl Tyrosine Kinase

1998-1999
Kenneth Kaushansky, MD
University of California
San Diego School of Medicine, San Diego, CA
Thrombopoietin from Theory to Reality

1997-1998
Richard Champlin, MD
M.D. Anderson Cancer Center, Houston, TX
Advances in Alloteneich Blood and Marrow Transplantation for Leukemia

1996-1997
A. Thomas Look, MD
Dana Farber Cancer Institute
Harvard Medical School, Boston, MA
Reversal of Apoptosis by Leukemia Associated E2a-Hlf Chimeric Transcription Factor

1995-1996
Ernest Beutler, MD
The Scripps Research Institute
Scripps Clinic Medical Group, La Jolla, CA
2-Chlorodeoxyadenosine (2CdA):
The Unconventional Development of a New Drug

1994-1993
Jerome Ritz, MD
Dana-Farber Cancer Institute
Harvard Medical School, Boston, MA
The Use of Low Dose Interleukin-2 in the Treatment of Cancer

1993-1992
Alessandro Massimo Gianni, MD
Instituto Nazionale Tumori, Milan, Italy
Clinical Usefulness of Peripheral Blood Progenitor Cells

1992-1991
E. Donall Thomas, MD
Nobel Laureate, University of Washington
Fred Hutchinson Cancer Research Center, Seattle, WA
Bone Marrow Transplantation: An Overview

1991-1990
Jimmie Holland, MD
Memorial Sloan Kettering Cancer Center,
New York, NY
Psychological Dimensions of Cancer: Old Issues,
New Challenges

1990-1991
Albert Deisseroth, MD, PhD
The Sidney Kimmel Cancer Center,
San Diego, CA
New Advances in Treatment of AML